[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344630-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344630-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","rare-cancer-explorer-10-race-10-a-dedicated-database-and-analytical-platform-focused-on-rare-cancers","Rare Cancer Explorer 1.0 (RaCE 1.0) - a dedicated database and analytical platform focused on rare cancers","","Rare cancers face major research challenges due to limited sample sizes and data scarcity. Existing pan-cancer resources largely target common cancer types, whereas rare cancers suffer from insufficient attention and lack systematic data collection. High heterogeneity and the shortage of studies on genomic features, immune environments, and drug responses create substantial gaps in current databases and analytical tools. To address these limitations, RaCE provides integrated curation, analysis, and visualization for rare cancers using 5451 samples across 13 solid tumor types from 69 datasets, plus dedicated functional modules for transcriptomics, immune infiltration, and immunotherapy response prediction.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/rare-cancer-explorer-10-race-10-a-dedicated-database-and-analytical-platform-focused-on-rare-cancers/344630/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/rare-cancer-explorer-10-race-10-a-dedicated-database-and-analytical-platform-focused-on-rare-cancers/344630.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does RaCE 1.0 address for rare cancer research?","Question",{"text":63,"@type":64},"RaCE 1.0 addresses the lack of sufficient data and systematic analytical tools for rare cancers, which are hindered by limited sample sizes and high heterogeneity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What does the RaCE 1.0 database include in terms of data coverage?",{"text":68,"@type":64},"RaCE 1.0 consolidates 5451 samples spanning 13 rare solid tumor types from 69 independent datasets.",{"name":70,"@type":61,"acceptedAnswer":71},"What analytical modules does RaCE 1.0 provide?",{"text":72,"@type":64},"RaCE includes an integrated dataset meta-analysis module and eight dedicated functional analysis modules, covering areas such as transcriptomics, immune infiltration, and immunotherapy response prediction.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344630,1790293410,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":26,"preview_urls":147},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Nucleic Acids Research, 2026, 54, D1590–D1607  \n[https://doi.org/10.1093/nar/gkaf911](https://doi.org/10.1093/nar/gkaf911)  \nAdvance access publication date: 24 September 2025  \nDatabase issue  \nRare Cancer Explorer 1.0 (RaCE 1.0): a dedicated database and analytical platform focused on rare cancers  \nYihao Chen 1 ,2 ,†, Le Zhang2 ,†, Chuanfan Zhong3 ,†, Songbo Li4 , Ruidong Li 2 , Zhenyu Jia 2 ,5 , Peisheng Huang6 , Shuo Wang1 , Zitao He 1 ,3 , Huawei Lin7 , Xiaowen Lin7 , Kai Chen8 ,  \nZhuoya Huang9 , Shanshan Mo1 , Zhouda Cai1 , Junhong Deng1 , Weide Zhong3 , 10 , 11 , *, Jiahong Chen6 , *, Jianming Lu 1 ,3 , *  \n1 Department of Andrology, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong 510180, China  \n2 Genetics, Genomics, and Bioinformatics Program, University of California, Riverside, CA 92521, United States  \n3 Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510180, China  \n4 Department of Urology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, The Second People’s Hospital of Guangxi Zhuang Autonomous Region, Guilin 541002, China  \n5 Department of Botany and Plant Sciences, University of California, Riverside, CA 92521, United States  \n6 Department of Urology, Huizhou Central People’s Hospital, Huizhou, Guangdong 516001, China  \n7The Second Clinical College, Guangzhou Medical University, Guangzhou, Guangdong 510180, China  \n8 Department of Pathology, Guangzhou Medical University Affiliated Women and Children’s Medical Center, Guangzhou, Guangdong 510623, China  \n9 Department of Pathology, Huizhou Central People’s Hospital, Huizhou, Guangdong 516001, China  \n10 State Key Laboratory of Mechanism and Quality of Chinese Medicine, Macau University of Science and Technology, Taipa 999078, China  \n11 Guangdong Provincial Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, Guangdong 510230, China  \n* To whom correspondence should be addressed. Email: [louiscfc8@gmail.com](louiscfc8@gmail.com)  \nCorrespondence may also be addressed to Jiahong [Chen. Email: ys_chen@163.com](Chen. Email: ys_chen@163.com)  \nCorrespondence may also be addressed [to Weide Zhong. Email: wdzhong@must.edu.mo](to Weide Zhong. Email: wdzhong@must.edu.mo)[ ](to Weide Zhong. Email: wdzhong@must.edu.mo)†The first three authors should be regarded as Joint First Authors.  \nAbstract  \nRare cancers face major research challenges due to limited sample sizes and data scarcity. Existing pan-cancer databases mainly focus on common cancer types, while rare cancers often lack sufficient attention and systematic data collection. In addition, their high heterogeneity and the scarcity of studies on genomic features, immune environments, and drug responses lead to significant gaps in current databases and analytical tools. To address these limitations, we developed the Rare Cancer Explorer (RaCE), a dedicated database for integrated curation, analysis, and visualization of rare cancers. RaCE consolidates 5451 samples spanning 13 rare solid tumor types from 69 independent datasets, offering researchers a one-stop data analysis toolkit. The database provides one integrated dataset meta-analysis module and eight dedicated rare cancer functional analysis modules, including transcriptomics, immune infiltration, and immunotherapy response prediction, with a specialized focus on modeling gene effects and drug sensitivity in rare cancer cell lines. RaCE distinguishes itself through robust interactive functionalities, enabling users to seamlessly explore multi-layered insights from gene functions to therapeutic targets, thereby accelerating precision medicine and translational research for rare cancers. Compared to existing databases, RaCE demonstrates unique advantages in supporting rare cancer re","cbCaikc8G8TqACIT","https://ap.wps.com/l/cbCaikc8G8TqACIT","pdf",5508955,18,"English","# Abstract\n## Database overview and scope\n## Data integration and modules\n## Access and usability\n# Introduction\n## Definition of rare cancers\n## International incidence thresholds","[{\"question\":\"What problem does RaCE 1.0 address for rare cancer research?\",\"answer\":\"RaCE 1.0 addresses the lack of sufficient data and systematic analytical tools for rare cancers, which are hindered by limited sample sizes and high heterogeneity.\"},{\"question\":\"What does the RaCE 1.0 database include in terms of data coverage?\",\"answer\":\"RaCE 1.0 consolidates 5451 samples spanning 13 rare solid tumor types from 69 independent datasets.\"},{\"question\":\"What analytical modules does RaCE 1.0 provide?\",\"answer\":\"RaCE includes an integrated dataset meta-analysis module and eight dedicated functional analysis modules, covering areas such as transcriptomics, immune infiltration, and immunotherapy response prediction.\"}]","Rare Cancer Explorer 1.0 (RaCE 1.0) - a dedicated database and analytical platform focused on rare cancers | PDF",1790054692,45,[148,152],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/abe65e3b23642c745769967db350a441.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/9e1b453c216867ea794f64f2d386fca5.webp",982,1270]